BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $156,272,835 | -31.4% | 6,497,831 | -9.0% | 0.01% | -26.3% |
Q2 2023 | $227,907,036 | -38.9% | 7,137,709 | -41.4% | 0.02% | +11.8% |
Q1 2023 | $372,801,750 | +91.9% | 12,175,106 | +145.2% | 0.02% | -10.5% |
Q4 2022 | $194,219,832 | -11.1% | 4,965,989 | +8.3% | 0.02% | -17.4% |
Q3 2022 | $218,389,000 | +17.5% | 4,584,135 | -4.5% | 0.02% | +21.1% |
Q2 2022 | $185,812,000 | -40.1% | 4,800,099 | -11.4% | 0.02% | -24.0% |
Q1 2022 | $310,285,000 | -0.7% | 5,415,096 | +38.1% | 0.02% | +8.7% |
Q4 2021 | $312,488,000 | -8.5% | 3,921,303 | -0.1% | 0.02% | -14.8% |
Q3 2021 | $341,442,000 | -65.5% | 3,924,166 | -48.9% | 0.03% | -64.9% |
Q2 2021 | $989,170,000 | +60.8% | 7,685,260 | +0.0% | 0.08% | +45.3% |
Q1 2021 | $615,128,000 | +2.8% | 7,685,259 | +4.9% | 0.05% | 0.0% |
Q4 2020 | $598,306,000 | +231.6% | 7,328,586 | 0.0% | 0.05% | +194.4% |
Q3 2020 | $180,430,000 | -7.6% | 7,328,586 | +5.1% | 0.02% | -14.3% |
Q2 2020 | $195,214,000 | +55.6% | 6,971,912 | 0.0% | 0.02% | +23.5% |
Q1 2020 | $125,494,000 | – | 6,971,912 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |